EX-16.1 8 tm2326791d1_ex16-1.htm EXHIBIT 16.1

Exhibit 16.1

 

September 26, 2023

 

Securities and Exchange Commission

100 F Street, N.E.

Washington, DC 20549

 

Commissioners:

 

We have read the statements made by American Oncology Network, Inc. (formerly Digital Transformation Opportunities Corp.) under Item 4.01 of its Form 8-K dated September 20, 2023. We agree with the statements concerning our Firm in such Form 8-K; we are not in a position to agree or disagree with other statements contained therein.

 

Very truly yours,

 

/s/ Marcum llp

 

Marcum llp

Houston, Texas